Cancer, Oral Melanoma


Article Author:
Patrick Zito


Article Editor:
Thomas Mazzoni


Editors In Chief:
Stephen Leslie
Karim Hamawy


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Kyle Blair
Trevor Nezwek
Radia Jamil
Erin Hughes
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Navid Mahabadi
Hussain Sajjad
Steve Bhimji
Muhammad Hashmi
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Abbey Smiley
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Daniyal Ameen
Altif Muneeb
Beenish Sohail
Nazia Sadiq
Hajira Basit
Phillip Hynes
Komal Shaheen
Sandeep Sekhon


Updated:
2/16/2019 10:35:29 AM

Introduction

Melanocytes arise from neural crest cells and are frequently found in the skin. However, melanocytes are also found in mucosal membranes. Melanocytes in mucosal membranes are distributed to the oral cavity, nasal cavity, paranasal sinuses, esophagus, larynx, vagina, cervix, rectum, and anus. Melanoma results from a malignant change of melanocytes. Melanoma in the head and neck account for upward of 25% of all melanomas. Mucosal melanomas account for less than 1% of all melanoma. However, mucosal melanoma accounts for roughly 10% of melanoma of the head and neck. The most common sites for mucosal melanoma in order are nasal, paranasal sinuses, oral cavity, and nasopharynx. Of all mucosal melanomas, paranasal sinus has the worst prognosis. The best prognosis locations are the nasal and oral cavity. In 1885, the first case of oral melanoma was reported.  Approximately 80% of oral malignant melanomas develop in the mucosa of the upper jaws (maxillary anterior gingiva). Majority of these lesions occur in the keratinizing mucosa of the palate and alveolar gingivae. Lesions are frequently asymptomatic until ulceration and hemorrhage are present. Compared with other melanomas, mucosal melanomas have the lowest percentage of 5-year survival. There is a poor 5-year survival at approximately 15% to 30% likely due to delayed detection.[1][2][3][4]

Etiology

Etiology is mostly unclear in malignant melanoma of the mouth. Mucosal melanoma of the mouth is not related to sun exposure. Risk factors largely remain obscure. Denture irritation, alcohol, and cigarette smoking have been listed as possible risk factors, but a direct relation is not substantiated.

Epidemiology

The peak age for diagnosis of mucosal melanoma is between 65 and 79 years, which is 1 to 2 decades later than cutaneous melanoma. Mucosal melanomas are found more so in women than in men. However, in oral malignant melanoma, gender distribution is reported as 1:1. Melanoma of the lip has a slightly male predominance. Malignant melanoma of the mouth has a higher prevalence in blacks, Japanese, and Indians of Asia.  The higher prevalence may be due to the higher published reports than actual rates.

Pathophysiology

Melanoma develops from a malignant transformation of melanocytes.  A number of pathways have been identified.

Mutations in c-KIT

Recent data indicates that c-KIT (CD117) is overexpressed in upward of 80% of mucosal melanoma cases. This pathway is important and common in acral and mucosal melanoma, melanomas unrelated to sun exposure. KIT is a transmembrane tyrosine kinase receptor that is expressed on hematopoietic progenitor cells, melanocytes, mast cells, primordial germ cells, and interstitial cells of Cajal. Activating mutations and amplifications cause activation of growth and proliferation pathways. New drugs, such as imatinib, work on this pathway.

Mutations in BRAF

Bioinformatics Resources and Applications Facility (BRAF) protein mutations are uncommon in mucosal melanoma and found at less than 10% of cases. However, in cutaneous melanoma, BRAF mutations are found in up to 80% of melanomas.

Histopathology

The mucosa of the mouth differs from the skin. Due to the lack of histological landmarks that are analogous to the papillary, reticular dermis, and muscle bundles, a pathological leveling system and description cannot be applied properly for mucosal melanomas. Therefore, use of Clark’s levels, which are commonly used in cutaneous melanoma, are unable to be used. Many melanomas in the mouth have a histologic with lentigo maligna melanoma in a radial growth phase. 

The mucosal melanomas can show 2 principal patterns: an in situ pattern and an invasive pattern. Approximately 15% of cases of oral melanoma are in situ mucosal lesions, 30% of cases are invasive lesions, and 55% of cases have a combined pattern of invasive with in situ components. Most advanced lesions have a combination pattern of invasive melanoma with in situ component.

Melanocytic Markers

S100

  • Common marker for neural tissue; acidic protein in the nucleus and cytoplasm
  • Used in the workup for desmoplastic melanoma

MART-1 (MELAN-A)

  • Most sensitive melanocytic marker
  • Can stain pseudonests in lichenoid actinic keratosis in sun-damaged skin
  • Note that in desmoplastic melanoma, MART-1 is usually negative and S100 must be performed.

MITF-1

  • Nuclear stain, positive in melanocytes, mast cells, and osteoclasts

HMB-45

  • Recognizes melanosomal glycoprotein gp100
  • Blue nevi stain with HMB-45

History and Physical

The initial presentation of malignant melanoma of the mouth is often swelling that is usually with a brown, dark blue, or black macule.  Satellite foci may surround the primary lesion. Just like cutaneous melanomas, melanoma in the mouth may be asymmetric with irregular borders. In amelanotic melanomas, pigmentation is not present. Amelanotic melanomas may simulate pyogenic granulomas. Many times, due to late diagnosis, erythema and ulceration may be present.

Treatment / Management

Surgery is the mainstay of treatment in oral malignant melanoma. Radical excision with disease-free margins is the first goal in the surgical management. Diagnostic excisional biopsy followed by wide local excision where the diagnosis is proven. Following complete surgical excision, relapse rates have been reported to be 10% to 20%.[5][6][7][8]

Neck Dissection

In a clinically positive neck, a neck dissection is mandatory in all cases of head and neck mucosal melanoma that is amenable to radical treatment.

Sentinel Lymph Node Biopsy/Lymphoscintigraphy

Has less value in staging and is less useful in predicting lymphatic drainage patterns in oral melanoma.

Radiotherapy

Radiotherapy is used to control local disease. This is in contrast to cutaneous melanoma.  Radiotherapy is valuable in the goal of achieving relapse-free survival.

Medical Therapy

Due to the low incidence of oral melanoma, well-controlled trials with large participants have been limited. Chemotherapy and immunotherapy may have a role in the prevention of metastatic disease.

Differential Diagnosis

The differential diagnosis of oral melanoma involves anything that can cause pigmentation within the mouth:

  • Oral melanotic macule
  • Amalgam tattoo
  • Labial lentigines
  • Physiologic pigmentation
  • Smoking associated melanosis
  • Postinflammatory pigmentation
  • Melanotic nevi of oral mucosa
  • Blue nevi
  • Melanoacanthoma
  • Melanoplakia
  • Medication-induced melanosis (examples:  minocycline and antimalarial drugs)
  • Peutz-Jeghers syndrome
  • Cushing syndrome
  • Addison’s disease
  • Kaposi sarcoma
  • Malignant melanoma
  • Amelanotic melanoma

Staging

Tumor, T

There is no T1 or T2 in mucosal melanoma.

  • T3: Tumors limited to the mucosa and immediately underlying soft tissue, regardless of thickness or greatest dimension; for example, polypoid nasal disease, pigmented or non-pigmented lesions of the oral cavity, pharynx, or larynx
  • T4: Moderately advanced or very advanced
  • T4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone, or overlying skin
  • T4b: Very advanced disease. Tumor involving the brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space, or mediastinal structures

Lymph Nodes, N

  • NX: Regional lymph nodes cannot be assessed
  • N0: No regional lymph node metastases
  • N1: Regional lymph node metastases present

Distant Metastases, M

  • M0: No distance metastasis
  • M1: Distant metastasis

Prognosis

Overall, the prognosis of malignant melanoma is poor with a 5-year survival at most 30% often due to late diagnosis. 

Independent prognostic factors that have been suggested are:

  • Tumor thickness greater than 5 mm
  • Ulceration
  • Greater than 10 mitotic figures per high power fields

Complications

After complete surgical excision, relapse rates have been reported to be 10% to 20%. Recurrence has been noted even up to 11 years following surgery. 

Metastases to the lymph nodes of the neck, lungs, liver, and brain

Consultations

Melanoma care and treatment requires a multidisciplinary approach. Melanomas of the head and neck, specifically the mouth, have a poor prognosis and often have advanced disease. Consultations with otolaryngology (head and neck surgery), surgical oncology, pathology, speech therapy, and other specialists depending on complications and distant metastases are warranted.

Deterrence and Patient Education

Patients with a history of oral melanoma require lifelong follow-up.

Pearls and Other Issues

Primary mucosal melanomas are aggressive tumors that are rarer than cutaneous melanoma. Head and neck mucosal melanomas are the most common. Wide excision is the treatment of choice. Oral melanoma complicated in that detection does not usually occur until the lesion is advanced. Overall 5-year survival is low which highlights the need for aggressive treatment and continued follow-up afterward. Detection of c-KIT mutations has been identified in upwards of 80% of mucosal melanomas and as little as 10% of BRAF mutations; this is opposite of cutaneous melanoma. Newer drugs such as imatinib are used in c-KIT pathway melanomas. It is important to maintain a high index of suspicion with pigmented lesions within the oral cavity, especially those in sites most common to oral melanoma (palate and maxillary gingiva).

Enhancing Healthcare Team Outcomes

The management of oral malignant melanoma is with a multidisciplinary team that includes an oncologist, oral surgeon, head and neck surgeon, plastic surgeon, radiation therapist, and a pulmonologist. Surgery is the mainstay of treatment in oral malignant melanoma. Radical excision with disease-free margins is the first goal in the surgical management. In general, primary mucosal melanomas are aggressive tumors that are rarer than cutaneous melanoma. Oral melanoma complicated in that detection does not usually occur until the lesion is advanced. Overall 5-year survival is low which highlights the need for aggressive treatment and continued follow-up afterward. Newer drugs such as imatinib are used in c-KIT pathway melanomas. The primary care physician and nurse provider should always maintain a high index of suspicion with pigmented lesions within the oral cavity, especially those in sites most common to oral melanoma (palate and maxillary gingiva). Due to the low incidence of oral melanoma, well-controlled trials with large participants have been limited.[9][10] (Level V)


  • Image 2512 Not availableImage 2512 Not available
    Contributed by Gray's Anatomy Plates
Attributed To: Contributed by Gray's Anatomy Plates

Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Cancer, Oral Melanoma - Questions

Take a quiz of the questions on this article.

Take Quiz
Which of the following is incorrect regarding the epidemiology of mucosal melanoma?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
In the case of oral malignant melanoma, which pathway is the most common?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What is the most common location for oral malignant melanoma?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What is the TMN classification of an oral malignant melanoma with 0.8 mm thickness, no regional lymph node metastasis, and no distant metastasis?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following is true regarding malignant melanoma of the mouth?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following is false concerning mucosal melanomas?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Cancer, Oral Melanoma - References

References

Unusual Cancers of Childhood Treatment (PDQ®): Health Professional Version 2002;     [PubMed]
Panda S,Dash S,Besra K,Samantaray S,Pathy PC,Rout N, Clinicopathological study of malignant melanoma in a regional cancer center. Indian journal of cancer. 2018 Jul-Sep;     [PubMed]
Natarajan E, Black and Brown Oro-facial Mucocutaneous Neoplasms. Head and neck pathology. 2019 Jan 29;     [PubMed]
Lee JS,Lee H,Lee S,Kang JH,Lee SH,Kim SG,Cho ES,Kim NH,Yook JI,Kim SY, Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation. EBioMedicine. 2019 Jan 24;     [PubMed]
Markman RL,Rosa GA,Cardili L,Simonato LE,Brandão TB,Ribeiro AC, Tongue metastasis of cutaneous melanoma: Report of two cases and literature review. Journal of clinical and experimental dentistry. 2018 Nov;     [PubMed]
Mayo Z,Seyedin S,Marquardt M,Mohiuddin I,Milhem M,Liu V,Pagedar N,Anderson C, Cutaneous malignant melanoma of the oral cavity following skin graft reconstruction: Case report. Head     [PubMed]
Maymone MBC,Greer RO,Kesecker J,Sahitya PC,Burdine LK,Cheng AD,Maymone AC,Vashi NA, Premalignant and Malignant Mucosal lesions: Clinical and Pathological Findings Part II. Premalignant and malignant mucosal lesions. Journal of the American Academy of Dermatology. 2018 Nov 14;     [PubMed]
Williams MD,Franchi A,Helliwell T,Müller S,Thompson LDR, Data Set for Reporting of Mucosal Melanomas of the Head and Neck: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting. Archives of pathology     [PubMed]
Oranges CM,Sisti G,Nasioudis D,Tremp M,DI Summa PG,Kalbermatten DF,Largo RD,Schaefer DJ, Hard Palate Melanoma: A Population-based Analysis of Epidemiology and Survival Outcomes. Anticancer research. 2018 Oct;     [PubMed]
Dalal AJ,Ingham J,Collard B,Merrick G, Review of outcomes of 500 consecutive cases of non-melanoma skin cancer of the head and neck managed in an oral and maxillofacial surgical unit in a District General Hospital. The British journal of oral     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Surgery-Urologic. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Surgery-Urologic, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Surgery-Urologic, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Surgery-Urologic. When it is time for the Surgery-Urologic board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Surgery-Urologic.